CUE BIOPHARMA INC (CUE) Stock Balance Sheet
NASDAQ:CUE - US22978P1066 - Common Stock
0.7802 USD
-0.02 (-2.66%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 27.49M | 22.46M | 48.51M | 51.61M | 64.37M | |||
| Marketable Securities | N/A | N/A | 0.00 | 24.67M | 0.00 | |||
| Receivables | 532.00K | 945.00K | 1.70M | 60.00K | 3.14M | |||
| Other Current Assets | 2.82M | 1.73M | 1.24M | 840.00K | 950.00K | |||
| Total Current Assets | 30.84M | 25.14M | 51.45M | 77.19M | 68.47M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.57M | 4.84M | 7.12M | 10.70M | 11.92M | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 2.39M | 2.21M | 2.96M | 3.39M | 3.01M | |||
| Total Non-Current Assets | 9.86M | 7.05M | 10.08M | 14.09M | 14.93M | |||
| TOTAL ASSETS | 40.71M | 32.19M | 61.53M | 91.28M | 83.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 2.42M | 4.33M | 3.96M | 1.96M | N/A | |||
| Accrued Expenses | 2.63M | 5.67M | 5.93M | 5.82M | 7.29M | |||
| Accounts Payable | 3.63M | 2.82M | 3.50M | 2.73M | 2.59M | |||
| Other Current Liabilities | 10.59M | 867.00K | 3.69M | 1.04M | 2.91M | |||
| Total Current Liabilities | 19.25M | 13.69M | 17.08M | 11.55M | 12.79M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 190.00K | 0.00 | 4.20M | 8.03M | 0.00 | |||
| Other Non-Current Liabilities | 3.10M | 1.00M | 3.16M | 6.02M | 5.12M | |||
| Total Non-Current Liabilities | 3.29M | 1.00M | 7.36M | 14.05M | 5.12M | |||
| TOTAL LIABILITIES | 22.55M | 14.69M | 24.45M | 25.60M | 17.91M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -362.60M | -341.86M | -301.19M | -250.46M | -197.45M | |||
| Additional Paid In Capital | 380.69M | 359.30M | 338.23M | 316.19M | 262.91M | |||
| Common Shares | 76.00K | 62.00K | 47.00K | 40.00K | 30.00K | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | -100.00K | 0.00 | |||
| Shares Outstanding | 76.45M | 61.82M | 47.22M | 43.04M | 32.20M | |||
| Tangible Book Value per Share | 0.24 | 0.28 | 0.79 | 1.53 | 2.03 | |||
| Total Shareholders' Equity | 18.16M | 17.50M | 37.09M | 65.68M | 65.49M | |||
| TOTAL LIABILITIES AND EQUITY | 40.71M | 32.19M | 61.53M | 91.28M | 83.40M | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | N/A | 0.11 | 0.12 | N/A | |||
| Current Ratio | 1.60 | 1.84 | 3.01 | 6.68 | 5.35 | |||
| Return On Assets (ROA) | -95.55% | -126.35% | -82.45% | -58.07% | -52.95% | |||
| Return On Equity (ROE) | -214.19% | -232.44% | -136.80% | -80.71% | -67.43% | |||
All data in USD , ROIC based on taxRate of 0.21